Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study

Back

ESC Professional Premium Access

Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study

Session: Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor J. Gumprecht (Zabrze, PL)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Jakub Gumprecht

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

0 follower

6 more presentations in this session

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation

Speaker: Doctor G. Moschovitis (Lugano, CH)

Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients

Speaker: Doctor U. Baumer (Vienna, AT)

Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

Speaker: Ms A. Lizancos Castro (Vigo, ES)

Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study

Speaker: Mr C. Tsang (Hong Kong, HK)

Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization

Speaker: Mr S. Majumder (Minneapolis, US)

Access the full session

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Speakers: Doctor J. Gumprecht, Doctor G. Moschovitis, Doctor U. Baumer, Ms A. Lizancos Castro, Mr C. Tsang...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study

About the speaker

Doctor Jakub Gumprecht

6 more presentations in this session

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation

Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients

Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study

Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization

Access the full session

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

About the event

ESC Congress 2023

ESC 365 is supported by